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Results: Five randomized trials of Early PCI only
met the inclusion criteria. Early PCI is associated with
improved cardiovascular events with no significant
bleeding complications. There is minimal clinical het-
erogeneity and insignificant statistical heterogeneity
(I2 = 12.6%, p = 0.33) among the five randomized con-
trol trials. The median time for needle to balloon is
4 h.
Conclusion: Early PCI should be incorporated in
the treatment of all ST-segment elevation myocardial
infarction. The median time for needle to balloon is
4 h.
http://dx.doi:10.1016/j.jsha.2013.03.150
Chronic venous insufficiency: Prevalence and
effect of compression stockings
Nourah Al-Hamdan, Bushra Al-Huthaly,
Farid Midhet, A. Rahman Almohaimeed, Mahboob
Hussain, Owayed Mohammad Al Shammeri
Introduction: Chronic venous insufficiency (CVI) is
a common disease affecting mainly lower limbs leading
to significant impact on the quality of life. There is no
study, to our knowledge, has attempted to evaluate the
impact of compression stockings on all patients with
CVI. Our aim is to estimate the prevalence of CVI in Qas-
sim and to test the effectiveness of compression
stockings.
Methods: Screening for CVI among patients visiting
the primary health care centers in Qassim until we
reached 100 CVI patients diagnosed using the clinical,
etiologic, anatomical, and pathophysiological (CEAP)
classification. Then CVI patients randomized to compres-
sion stocking or standard medical therapy. Clinical follow
up using multiple scale system including CEAP scale.
Data analysis was performed using SPSS, version 17.0.
We used chi-square test, ANOVA and linear regression
to assess the impact of compression stockings on the clin-
ical and venous scores of CVI before and after the
intervention.
Results: Among the 226 screened patients, 138
(61.1%) were diagnosed to have CVI (69% in females
and 45% in males, p < 0.001). Compared to baseline, both
the clinical and venous scores for CVI at the follow-up
were significantly lower among patients using compres-
sion stockings, p = 0.002 and p = 0.003, respectively.
Regression analysis suggested that, after controlling for
age, sex and body mass index, compliance was the main
factor responsible for a significant reduction in the clini-
cal score among CVI patients.
Conclusions: Chronic venous insufficiency is very
common in Qassim, 61%. Compression stocking is highly
effective in improving clinical symptoms and signs of
CVI.
http://dx.doi:10.1016/j.jsha.2013.03.151
Stemi: Thrombus charateristics and no reflow
phoenomenon
Bushra E. Alhothaly, Owayed Mohammad Al
Shammeri, Adel Azmy, Abdullah Alghamdi,
Mahboob Ali Dar, Yaser Bashir
Background: The ‘‘no-reflow’’ phenomenon refers to
the absence of myocardial perfusion after opening the
infarct-related artery during Percutaneous Coronary
Interventions (PCI). ‘‘No-reflow’’ phenomenon is associ-
ated with malignant arrhythmia, advanced left ventricu-
lar remodeling, congestive heart failure, and cardiac
death. We aim to Study the gross appearance and histo-
pathology of the extracted thrombus that may suggests
variables to predict the occurrence of ‘‘no reflow’’
phenomenon.
Methods: Twenty-five consecutive cases ST-segment
elevation myocardial infarction (STEMI) treated by PCI
using thrombectomy in Prince Sultan Cardiac Centre in
Qassim were studies. Detailed Clinical, angiographic
and histopathologic data were obtained. ‘‘No reflow’’ is
diagnosed the presence of one of two criteria: (1) failure
to obtain >70% of ST-segment resolution; (2) TIMI flow
rate < 3. Chisquare test was used to compare the
proportions.
Results: ‘‘No reflow’’ diagnosed in 14 patients (56%).
The histopathology data suggested the majority of STEMI
had recent thrombus, 19 out of 25 patients, but no differ-
ent between ‘‘no reflow’’ and normal flow groups, 11 ver-
sus 8, respectively; p = 0.73). The gross color of thrombus
among patients with ‘‘no reflow’’ tend to be darker color,
12 versus 9 in ‘‘no reflow’’ and normal flow, respectively;
p = 0.39. Though both observations were not statistically
significant due to probably small sample size.
Conclusion: ‘‘No reflow’’ is common phenomenon
during percutaneous coronary intervention in ST-seg-
ment elevation myocardial infarction. Larger scale study
needed to test the observation of darker color thrombus
may alert the development of ‘‘no reflow’’.
http://dx.doi:10.1016/j.jsha.2013.03.152
Demographic, clinical and device profiles of 5580
patients implanted with IPG in a geographically
diverse population
Raed Abdelhallim Sweidan, Janis Ansabergs,
Faizel Lorgat, Pedro Ureña, Ulhas Pandurangi,
Fawziah Alkandari
Background & Objective: We describe demo-
graphic, clinical and programming characteristics of a
geographically diverse population implanted with an
IPG, with a focus of patients enrolled from Middle East
(ME).
Methods: Data were obtained from PANORAMA, a
long term, prospective observational study of 8522
patients from 34 countries implanted with a cardiac
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rhythm management device between 2005 and 2011. This
analysis is based on the 5580 (65%) that were implanted
with an IPG, of which 782 patients were enrolled from
the ME (Kuwait n = 361 and Saudi Arabia n = 421).
Results: Compared to the other regions patients
from the ME were more likely to present with diabetes
(20% vs 37%, p < 0.001) and less likely to have NYHA
class II, III or IV (34% vs 7%, p < 0.001) or atrial fibrillation
(33% vs 17%, p < 0.001). The ME region had the highest
proportion of patients implanted with a single chamber
device and AV block indication.
Conclusion: The Panorama IPG cohort provides a
unique opportunity to examine the implant practices
and clinical profiles of patients implanted with an IPG
in the Middle East region. We found significant differ-
ences in patient characteristics, type of IPG, and choice
of programming. Further work is needed to understand
how these differences might contribute to differences in
patient management and outcomes.
http://dx.doi:10.1016/j.jsha.2013.03.153
Assessment of the hemodynamic changes follow-
ing fluid preloading in cardiac surgery
Raed Amrullah Alsatli
Department of Anesthesiologist, College of Medicine,
King Fahad Cardiac Center, King Saud University,
Riyadh, Saudi Arabia; Department of Cardiac Science,
P.O. Box: 7805 (Internal 92), College of Medicine, King
Saud University, Riyadh 11472, Saudi Arabia
Background: This prospective double-blind ran-
domized study aims to study the hemodynamic changes
following fluid preloading with Hydroxyethyl starch
(HES) 6% (130/0.4) compared with normal saline (NS)
in cardiac surgery patients.
Methods: Forty patients undergoing coronary artery
bypass grafting (CABG) were enrolled in this study, then
they were divided in 2 equal groups, HES and NS. After
fast administration of 10 mL/kg from either solutions
over 5 min only, hemodynamic parameters, such as heart
rate, mean arterial pressure (MAP), central venous pres-
sure (CVP), pulmonary artery occlusion pressure
(PAOP), mean pulmonary artery pressure, systemic vas-
cular resistance, and pulmonary vascular resistance were
measured every 5 min for the total duration of 40 min.
Results: There were significant differences in the cardiac
index measurements between both groups at 15 min
onward; also PAOP was significantly higher in HES
group at 10 min onward. CVP was higher in HES group
but statistically significant at 10 min only. MAP was
higher in HES group, but that was statistically significant
at 40 min only. On the other hand PAP was significantly
higher at 10 and 40 min.
Conclusion: Fluid preloading with HES led to a sig-
nificant increase in filling pressure of the left ventricle
(PAOP) and cardiac index compared with NS. We believe
that HES (130/0.4) could be a suitable solution for fluid
preloading in CABG surgery patients. However, further
studies are needed on different fluid preloading modali-
ties with different dosing regimens.
http://dx.doi:10.1016/j.jsha.2013.03.154
Impact of atrioventricular compliance on clinical
outcome of patients undergoing successful percu-
taneous balloon mitral valvuloplasty
Ragab Abdelsalam Mahfouz, Waled Elawady,
Ekhlas Hossein, Ahmad Yosri
Objective: We aimed to assess the impact of atrio-
ventricular compliance (Cn) on the clinical outcome, pul-
monary hypertension (PH) and right ventricular (RV)
function changes after successful percutaneous balloon
mitral valvuloplasty (PBMV).
Methods and results: Using Doppler echocardiogra-
phy Cn was estimated from the equation that has been
previously validated. Mitral valve area, tricuspid annular
plane systolic excursion (TAPSE), pulmonary artery pres-
sure (PAP) and degree of TR severity were evaluated
before, immediately and every 6 months with a median
duration of 32 months after successful PBMV in 150 con-
secutive patients. Compared to control subjects patients
with MS had significant lower Cn (P < 0.0001). An imme-
diate drop in PAP and significant improvement of RV
function was observed after PBMV. Cn was correlated
with the degree of PAPs, TAPSE (P < 0.0001). Patients
with Cn < 3.75 mL/mmHg had higher incidence of
adverse outcome (developing atrial fibrillation, worsen-
ing RV function, progressive left atrial dilation and redo
intervention). Multivariate regression analysis showed
that the Cn was the strongest independent predictor of
PAPs and RV functional before and after successful
PBMV (P < 0.0001). Cn < 3.75 mL/mmHg was the cut-of
value for prediction of clinical events at follow-up.
Conclusions: The change and follow-up in RV func-
tion and pulmonary hypertension after successful PBMV
were significantly correlated with the degree of Cn. This
suggests a significant role of Cn in patients with MS, pro-
viding a good insight for intervention and utilizing Cn as
a non-invasive hemodynamic index for risk stratification
and proper timing for intervention in patients with MS.
http://dx.doi:10.1016/j.jsha.2013.03.155
Drug-eluting balloon for de-novo, ISR and bifur-
cation lesions cad:Short and intermediate results,
prospective registry
Rida Mustafa Nourallah, Ali Almasoud, Menwar
Alanazi, Saad Alkasab
Adult cardiology, Prince Sultan Cardiac Center, Riyadh,
Saudi Arabia
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